SIGA - SIGA TECHNOLOGIES INC

5.8
-0.440   -7.586%

Share volume: 778,611
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.14%

PREVIOUS CLOSE
CHG
CHG%
$6.24
-0.44
-0.07%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
30%
Profitability 3%
Dept financing 50%
Liquidity 75%
Performance 42%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-6.75%
1 Month
-11.18%
3 Months
-5.69%
6 Months
-33.03%
1 Year
1.58%
2 Year
19.34%
Key data
Stock price
$5.80
P/E Ratio 
8.80
DAY RANGE
$5.78 - $6.16
EPS 
$1.04
52 WEEK RANGE
$4.95 - $9.62
52 WEEK CHANGE
$1.58
MARKET CAP 
655.195 M
YIELD 
6.56%
SHARES OUTSTANDING 
71.611 M
DIVIDEND
$0.60
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-06-2025
BETA 
1.77
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$693,637
AVERAGE 30 VOLUME 
$497,513
Company detail
CEO: Phillip L. Gomez
Region: US
Website: siga.com
Employees: 40
IPO year: 1997
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

SIGA Technologies, Inc. focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

Recent news